ChemicalBook >> CAS DataBase List >>H3B-6527

H3B-6527

CAS No.
1702259-66-2
Chemical Name:
H3B-6527
Synonyms
CS-2347;H3B-6527;H3 Biomedicine;H3B6527;H3B 6527;Eisai/H3 Biomedicine;H3B-6527, 10 mM in DMSO;H-3B-6527,H3B6527,H3B 6527;H3B-6527, 98%, a highly selective FGFR4 inhibitor with potent antitumour activity;N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide;2-Propenamide, N-[2-[[6-[[[(2,6-dichloro-3,5-dimethoxyphenyl)amino]carbonyl]methylamino]-4-pyrimidinyl]amino]-5-(4-ethyl-1-piperazinyl)phenyl]-
CBNumber:
CB23146613
Molecular Formula:
C29H34Cl2N8O4
Molecular Weight:
629.54
MDL Number:
MFCD30377210
MOL File:
1702259-66-2.mol
Last updated:2025-04-18 09:51:53

H3B-6527 Properties

Boiling point 832.1±65.0 °C(Predicted)
Density 1.373±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:50.0(Max Conc. mg/mL);79.42(Max Conc. mM)
form A solid
pka 11.00±0.70(Predicted)
color White to khaki
FDA UNII 4HTE364XIK

H3B-6527 price More Price(13)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 26072 H3B-6527 ≥98% 1702259-66-2 1mg $81 2024-03-01 Buy
Cayman Chemical 26072 H3B-6527 ≥98% 1702259-66-2 5mg $238 2024-03-01 Buy
Cayman Chemical 26072 H3B-6527 ≥98% 1702259-66-2 10mg $435 2024-03-01 Buy
Cayman Chemical 26072 H3B-6527 ≥98% 1702259-66-2 25mg $887 2024-03-01 Buy
AK Scientific 2308EF H3B-6527 1702259-66-2 1mg $187 2021-12-16 Buy
Product number Packaging Price Buy
26072 1mg $81 Buy
26072 5mg $238 Buy
26072 10mg $435 Buy
26072 25mg $887 Buy
2308EF 1mg $187 Buy

H3B-6527 Chemical Properties,Uses,Production

Uses

H3B-6527 is an orally active, highly selective and covalent FGFR4 inhibitor with an IC50 of <1.2 nM. H3B-6527 has at least 250-fold selectivity over FGFR1-3 with IC50s of 320 nM, 1290 nM and 1060 nM respectively. H3B-6527 has potent anti-cancer activity[1].

Biological Activity

H3B-6527 is a highly selective covalent FGFR4 inhibitor with IC50 < 1.2 nM, with >250-fold selectivity for FGFR4 over FGFR1-3 (IC50s of 320, 1290 and 1290 for FGFR1-3, respectively) 1060 nM).

in vitro

H3B-6527 has a strong inhibitory effect on FGFR4 with IC50 less than 1.2 nM. TAOK2, JNK2 and CSF1R were less sensitive to H3B-6527 treatment with IC50s of 690, >10000 and >10000 nmol/L, respectively. Treatment of Hep3B cells with H3B-6527 resulted in a concentration-dependent activation of caspase-3/7. It inhibits FGFR4 signaling, inhibits proliferation, and causes apoptosis in HCC cells.

in vivo

In a mouse model of Hep3B hepatocarcinoma xenografts, H3B-6527 had dose-proportional plasma exposure (greater than tumor exposure; doses tested were 30, 100, and 300 mg/kg). The pharmacodynamic response of H3B-6527 was detected, and it was found that CYP7A1 mRNA and pERK1/2 protein levels showed a concentration-dependent response, and higher concentrations would lead to a more durable response. In both subcutaneous Hep3B xenograft models and orthotopic xenograft models, oral administration of it (twice a day) significantly inhibited the growth of xenografts. Palbociclib enhanced the potency of it and promoted tumor regression in the JHH-7 model, whereas it single-agent administration only caused tumor growth arrest.

IC 50

FGFR4: <1.2 nM (IC50); FGFR1: 320 nM (IC50); FGFR2: 1290 nM (IC50); FGFR3: 1060 nM (IC50)

References

[1] Joshi JJ, et al. H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven HepatocellularCarcinoma. Cancer Res. 2017 Dec 15;77(24):6999-7013. DOI:10.1158/0008-5472.CAN-17-1865

H3B-6527 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 81)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19552 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6312 58
AFINE CHEMICALS LIMITED
+86-0571-85134551 sales@afinechem.com China 15417 58
Finetech Industry Limited
+86-27-8746-5837 +8619945049750 info@finetechnology-ind.com China 9642 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10473 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6391 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3135 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38663 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525 masar@topule.com China 8467 58
H3B-6527 N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide Eisai/H3 Biomedicine H3B-6527, 98%, a highly selective FGFR4 inhibitor with potent antitumour activity CS-2347 H3B6527;H3B 6527 2-Propenamide, N-[2-[[6-[[[(2,6-dichloro-3,5-dimethoxyphenyl)amino]carbonyl]methylamino]-4-pyrimidinyl]amino]-5-(4-ethyl-1-piperazinyl)phenyl]- H-3B-6527,H3B6527,H3B 6527 H3 Biomedicine H3B-6527, 10 mM in DMSO 1702259-66-2 C29H34Cl2N8O4